Key result
Mild COVID-19 recovery does not impair cardiac baroreflex sensitivity compared to uninfected controls.
Why the study?
It was unknown whether mild COVID-19 impairs cardiac baroreflex sensitivity in young healthy men and women 12-14 weeks after recovery.
Does mild COVID-19 infection impair cardiac baroreflex sensitivity in young healthy men and women?
Observational (n=27)
Does mild COVID-19 infection impair cardiac baroreflex sensitivity in young healthy men and women?
Answers are grounded in this paper and cite their sources.
Mild COVID-19 infection does not appear to cause long-term impairment of cardiac baroreflex sensitivity in young healthy individuals, despite a slight elevation in resting systolic blood pressure.
We sought to investigate whether mild COVID‐19 impairs cardiac baroreflex sensitivity (cBRS), using the modified Oxford protocol, in young healthy men and women 12–14 weeks after recovering from the infection. Participants were distributed into two groups: Non‐COVID‐19 group (NCG: men n = 6 [30 ± 3years; 26 ± 1 kg/m 2 ] and women n = 5 [25 ± 1 years; 25 ± 1 kg/m 2 ]) and recovered from COVID‐19 group (RCG: men n = 6 [29 ± 3 years; 25 ± 1 kg/m 2 ] and women n = 10 [32 ± 4 years; 22 ± 1 kg/m 2 ]), the RCG tested positive (RT‐PCR) 12 to 14 weeks before the protocol. Beat‐to‐beat finger blood pressure (BP) and heart rate (HR) were measured during a bolus of sodium nitroprusside (SNP) and phenylephrine (PHE), in a control condition and during cold pressor test (CPT) and moderate dynamic handgrip exercise (GRIP). Resting systolic BP was higher in the RCG (135 ± 14 mmHg vs. 122 ± 12 mmHg, p = 0.01). Both CPT and GRIP maneuvers increased HR and BP; the bolus of SNP diminished BP and evoked a reflex‐mediated increase in HR; PHE increased BP, resulting in a reflex‐mediated decrease in HR. Of note, cBRS for decrease or increase of BP did not differ between groups under the studied conditions: control (SNP, p = 0.39; PHE, p = 0.50); CPT (SNP, p = 0.09; PHE: p = 0.82); and GRIP (SNP, p = 0.35; PHE, p = 0.53). In conclusion, mild COVID‐19 did not seem to impair cBRS in healthy young men and women 12–14 weeks after recovering from the infection.
No takes yet. Share an insight, caveat, or question.
Souza et al. (2025) conducted an observational in Mild COVID-19 (n=27). Recovery from mild COVID-19 vs. Non-COVID-19 healthy controls was evaluated on Cardiac baroreflex sensitivity (cBRS). Mild COVID-19 recovery (12-14 weeks post-infection) did not impair cardiac baroreflex sensitivity during control, cold pressor, or handgrip tests compared to uninfected controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: